PCSK9 and metabolic syndrome: Based on the present results, it can be speculated that in such low risk population there could be a link between lower levels of PCSK9, a particular metabolic phenotype (low HDL cholesterol, the metabolic syndrome, obesity, insulin resistance and diabetes) and the propensity to develop diffuse coronary atherosclerosis.